|OTC: ZIVO||Healthcare / Biotechnology / USA|
|2.5400||+0.0050||+0.20%||Vol 14.31K||1Y Perf -35.00%|
|Mar 24th, 2023 16:00|
|- -||- -%|
|Target Price||9.00||Analyst Rating||— — 0.00|
|Potential %||254.33||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||+ 34.70|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Price Range Ratio 52W %||15.57||Earnings Rating||—|
|Market Cap||23.92M||Earnings Date||10th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|3 Years||2 209.09%|
|5 Years||2 465.66%|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||0|
|Avg. Monthly Volume||0|
|Avg. Quarterly Volume||0|
|Analyst Ratings||Current||1 M ago||3 M ago|
Zivo Bioscience Inc is a biotechnology company that is engaged in selling natural bioactive ingredients derived from proprietary algae cultures to an animal, human and dietary supplement and medical food manufacturers. The company focuses on research and identification of its bioactive ingredients. It also develops tests that allow people to optimize their health and identify future health risks. The company's product candidate ZIVO algae strain is a human dietary supplement that acts as a source of non-animal nutrition, animal supplement, and livestock feed additive, boosting productivity and overall health. Its other product categories are animal applications, human applications, functional food ingredient, dietary supplements and nutraceuticals, and medical food and Botanical Drug.
CEO: Andrew Dahl
Telephone: +1 248 452-9866
Address: 2804 Orchard Lake Road, Keego Harbor 48320, MI, US
Number of employees: 8
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.